Digital therapeutics are clinically validated software interventions — programs that treat, manage, or prevent medical conditions through evidence-based behavioral mechanisms. Unlike wellness apps or fitness trackers, digital therapeutics (DTx) are prescribed by clinicians, used by patients managing real medical conditions, and in many jurisdictions subject to FDA or regulatory clearance. When a digital therapeutics platform is unavailable, patients may miss therapeutic sessions, clinicians lose visibility into treatment adherence, and the clinical outcomes the platform was built to deliver are interrupted.
This guide covers uptime monitoring for digital therapeutics platforms in 2026: the clinical, regulatory, and technical dimensions of availability, what components require continuous monitoring, and how to configure Vigilmon for healthtech engineering teams.
Why Uptime Is Critical for Digital Therapeutics
Therapeutic dose delivery depends on platform availability. Digital therapeutics work through consistent, structured engagement — cognitive behavioral therapy modules, exposure therapy exercises, medication adherence reminders, or chronic disease management programs. A patient who opens the app during their scheduled therapeutic session and encounters an error or blank screen has missed a therapeutic dose. Unlike a missed workout, a missed DTx session may disrupt a carefully structured clinical protocol.
Clinician oversight requires continuous data access. Many DTx platforms include a care team dashboard where clinicians review patient engagement metrics, symptom reports, and adherence data between appointments. A dashboard that is unavailable during a clinical review cycle creates a gap in care team visibility. In conditions like depression, anxiety, or substance use disorders, where patient status can change rapidly, data gaps have clinical significance.
FDA clearance and regulatory status creates compliance obligations. DTx products cleared by the FDA as Software as a Medical Device (SaMD) or regulated under the De Novo pathway operate under quality system requirements that include post-market surveillance. Availability is part of the safety and performance profile that supports continued regulatory clearance. Incident documentation — including outage durations, affected features, and patient populations impacted — is expected evidence in regulatory reviews.
Healthcare partner integrations have contractual SLAs. DTx platforms that integrate with health systems, payers, or employer health programs typically operate under partnership agreements with defined availability requirements. A health system that prescribes your platform to patients expects it to be available. Repeated availability incidents create grounds for contract renegotiation or termination.
Patient vulnerability amplifies the impact of downtime. Digital therapeutics patients are by definition managing a health condition. Patients using a DTx platform for anxiety management who encounter repeated failures may experience the technical unreliability as a stressor. For patients managing conditions where the app is a central therapeutic tool, platform unavailability is not a neutral UX event.
What to Monitor on a Digital Therapeutics Platform
DTx platforms typically combine a patient-facing mobile/web application, a clinical care team dashboard, a data ingestion layer for patient-reported outcomes, integration endpoints for EHR systems, and a notification service for therapeutic reminders.
Patient application API. The backend API that powers the patient app — delivering therapy modules, receiving symptom check-ins, and logging engagement data. This is the primary therapeutic surface of the platform. Monitor the patient API entry point continuously. Response time matters as well as availability — a slow-loading therapy module degrades session completion rates.
Care team dashboard. The clinical interface through which physicians, therapists, and care coordinators review patient progress. Monitor the dashboard's authentication endpoint and the API that serves patient data. Unavailability here disrupts clinical workflows and, in integrated health system deployments, may trigger escalation from the health system's IT team.
Patient data ingestion service. The service that receives and stores patient-reported outcomes, symptom ratings, mood logs, and behavioral data. This component is often separate from the presentation layer. A silent failure in data ingestion means patient inputs are accepted in the UI but not stored — a particularly insidious failure mode that can persist for hours before detection. Monitor this endpoint independently.
EHR integration endpoint. DTx platforms integrated with electronic health records (via HL7 FHIR APIs or proprietary connectors) must maintain the integration connection for clinical data exchange. Monitor the outbound EHR connector and any inbound webhook receivers. EHR integration failures often appear in logs as non-critical errors but accumulate into meaningful data gaps.
Therapeutic notification service. Scheduled reminders, session prompts, and medication adherence alerts are core to many DTx protocols. Monitor the notification service endpoint. Silent failures in notification delivery reduce session engagement and may affect clinical outcomes in time-sensitive protocols (e.g., daily mood tracking required before weekly therapy sessions).
Authentication and identity service. Patients cannot access the platform without authentication. Monitor your identity provider endpoint as a first-class dependency — auth failures are a complete patient lockout regardless of the health of every other service.
Prescription and activation service. Many DTx platforms require a prescription activation step — patients receive a code from their clinician and activate it to begin the program. Monitor the activation endpoint. Failures here prevent newly prescribed patients from onboarding at all.
Vigilmon Setup for Digital Therapeutics Engineering Teams
Monitor the therapeutic critical path first. The highest-priority monitors are: patient authentication, patient API, and notification service. These three components are required for a patient to complete a therapeutic session. Set 1-minute check intervals and immediate alerting on all three.
Alert on response time, not just availability. DTx session completion rates are sensitive to loading speed — a module that takes 5 seconds to load has meaningfully lower completion rates than one that loads in 1 second. Configure response-time threshold alerts on the patient API: warn at 2 seconds, page at 5 seconds. Latency degradation is often the first indicator of infrastructure pressure before hard failures occur.
Monitor care team dashboard availability during clinical hours. Clinical review cycles typically happen between 8am and 6pm in the health system's time zone. Configure specific alerting windows for care team dashboard monitors, with immediate notification to on-call clinical ops during business hours. Outside those hours, keep the monitor active but use non-paging alerts.
Use multi-region monitoring for national deployments. DTx platforms deployed through national health systems or large employer programs serve geographically distributed patients. A regional outage that makes the platform inaccessible to patients in one region is a partial incident worth detecting. Vigilmon's multi-region consensus alerting fires when multiple probes confirm unavailability, filtering transient network noise.
Configure SSL certificate monitoring on all patient-facing domains. Certificate errors on a healthcare platform are particularly damaging — patients encountering browser security warnings on a health app may reasonably conclude their health data is at risk. Monitor certificate expiry with a 30-day alert window.
Create a partner-facing status page. Health system integration partners and payer partners need visibility into platform status. Publish the Vigilmon status page URL in your partner documentation and integration handbooks. Automated status updates reduce inbound calls from health system IT teams during incidents.
Alerting Strategy for Digital Therapeutics Platforms
Alert routing should reflect patient impact and clinical context:
Immediate page (24/7): Patient authentication service, patient application API. These two services are required for any patient interaction with the platform. Downtime at any hour affects patients in different time zones.
Immediate page (clinical hours): Care team dashboard, EHR integration endpoint. Clinical team availability issues during working hours warrant immediate response; out-of-hours degradation can typically wait for the next business day unless the EHR integration failure is accumulating data loss.
High-priority alert: Patient data ingestion service, therapeutic notification service. These failures may not be immediately visible to patients but create clinical data gaps that worsen over time.
Advance warning (30-day, 7-day): SSL certificate expiry on all patient-facing and partner-facing domains.
Conclusion
Digital therapeutics platforms carry a higher operational responsibility than most software: their users are patients managing health conditions, their partners include regulated health systems, and their products are clinical tools subject to regulatory oversight. Availability is not an infrastructure metric — it is a care delivery outcome. An unavailable DTx platform is a patient who missed a therapeutic session, a clinician who cannot review patient progress, and a health system partner who cannot fulfill its prescription.
Vigilmon provides external uptime and performance monitoring that complements your internal observability stack. For DTx engineering teams, that external check — simulating what a patient actually experiences when opening the app — is the layer of monitoring closest to clinical reality.
Start monitoring your digital therapeutics platform for free at vigilmon.online — HTTP/HTTPS monitoring, response-time alerting, multi-region consensus, SSL certificate monitoring, automatic status page, Slack and webhook integration. No agent required. No credit card.
Tags: #monitoring #digitaltherapeutics #healthtech #dtx #uptime #devops #sre #healthit #samd